BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2018075)

  • 21. A new DNA probe of potential use for diagnosis of the fragile-X syndrome.
    Lucotte G
    Ann Genet; 1990; 33(2):109-10. PubMed ID: 1978629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DXS539, a polymorphic DNA marker proximal of the fragile-X gene.
    Dreesen JC; van den Hurk JA; Smits AP; van den Ouweland AM; Markslag PW; van Oost BA
    Hum Genet; 1993 Mar; 91(1):80-2. PubMed ID: 8454292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic mapping of new DNA probes at Xq27 defines a strategy for DNA studies in the fragile X syndrome.
    Suthers GK; Mulley JC; Voelckel MA; Dahl N; Väisänen ML; Steinbach P; Glass IA; Schwartz CE; van Oost BA; Thibodeau SN
    Am J Hum Genet; 1991 Mar; 48(3):460-7. PubMed ID: 1671806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linkage homogeneity near the fragile X locus in normal and fragile X families.
    Suthers GK; Mulley JC; Voelckel MA; Dahl N; Väisänen ML; Steinbach P; Glass IA; Schwartz CE; van Oost BA; Thibodeau SN
    Genomics; 1991 Jul; 10(3):576-82. PubMed ID: 1889808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and physical mapping of a novel region close to the fragile X site on the human X chromosome.
    Patterson MN; Bell MV; Bloomfield J; Flint T; Dorkins H; Thibodeau SN; Schaid D; Bren G; Schwartz CE; Wieringa B
    Genomics; 1989 May; 4(4):570-8. PubMed ID: 2744766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multipoint genetic mapping of the Xq26-q28 region in families with fragile X mental retardation and in normal families reveals tight linkage of markers in q26-q27.
    Oberlé I; Camerino G; Wrogemann K; Arveiler B; Hanauer A; Raimondi E; Mandel JL
    Hum Genet; 1987 Sep; 77(1):60-5. PubMed ID: 3502701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multipoint linkage of 9 anonymous probes to HPRT, factor 9, and fragile X.
    Brown WT; Ye W; Gross AC; Chan CB; Dobkin CS; Jenkins EC
    Am J Med Genet; 1988; 30(1-2):551-66. PubMed ID: 2902796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linkage between the fragile X and F9, DXS52 (St14), DXS98 (4D-8) and DXS105 (cX55.7).
    Mulley J; Turner G; Bain S; Sutherland GR
    Am J Med Genet; 1988; 30(1-2):567-80. PubMed ID: 2902797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical and genetic mapping of the CDR gene with particular reference to its position with respect to the FRAXA site.
    Siniscalco M; Oberlé I; Melis P; Alhadeff B; Murray J; Filippi G; Mattioni T; Chen YT; Furneaux H; Old LJ
    Am J Med Genet; 1991; 38(2-3):357-62. PubMed ID: 1708201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multilocus analysis of the fragile X syndrome.
    Brown WT; Gross A; Chan C; Jenkins EC; Mandel JL; Oberlé I; Arveiler B; Novelli G; Thibodeau S; Hagerman R
    Hum Genet; 1988 Mar; 78(3):201-5. PubMed ID: 3162224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linkage analysis using multiple DNA polymorphic markers in normal families and in families with fragile X syndrome.
    Thibodeau SN; Dorkins HR; Faulk KR; Berry R; Smith AC; Hagerman R; King A; Davies KE
    Hum Genet; 1988 Jul; 79(3):219-27. PubMed ID: 3402993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical mapping of new DNA probes near the fragile X mutation (FRAXA) by using a panel of cell lines.
    Suthers GK; Hyland VJ; Callen DF; Oberle I; Rocchi M; Thomas NS; Morris CP; Schwartz CE; Schmidt M; Ropers HH
    Am J Hum Genet; 1990 Aug; 47(2):187-95. PubMed ID: 2378346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic mapping of two new DNA markers in Xq26-q28 relative to the fragile-X syndrome locus.
    Sood R; Mulligan LM; Poon R; White BN; Holden JJ
    Am J Hum Genet; 1990 Sep; 47(3):395-402. PubMed ID: 1975476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved DNA markers for efficient analysis of fragile X families.
    Heilig R; Oberlé I; Arveiler B; Hanauer A; Vidaud M; Mandel JL
    Am J Med Genet; 1988; 30(1-2):543-50. PubMed ID: 2902795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of a DNA probe of potential use for diagnosis of the fragile-X syndrome.
    Dahl N; Hammarström-Heeroma K; Goonewardena P; Wadelius C; Gustavson KH; Holmgren G; van Ommen GJ; Pettersson U
    Hum Genet; 1989 Jun; 82(3):216-8. PubMed ID: 2567272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fragile X syndrome in a large family. III. Investigations on linkage of flanking DNA markers with the fragile site Xq27.
    Veenema H; Carpenter NJ; Bakker E; Hofker MH; Ward AM; Pearson PL
    J Med Genet; 1987 Jul; 24(7):413-21. PubMed ID: 2886667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An assessment of the use of flanking DNA markers for fra(X) syndrome carrier detection and prenatal diagnosis.
    Forster-Gibson CJ; Mulligan LM; Simpson NE; White BN; Holden JJ
    Am J Med Genet; 1986; 23(1-2):665-83. PubMed ID: 3006491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linkage and genetic counselling for the fragile X using DNA probes 52A, F9, DX13, and ST14.
    Mulley JC; Gedeon AK; Thorn KA; Bates LJ; Sutherland GR
    Am J Med Genet; 1987 Jun; 27(2):435-48. PubMed ID: 2886048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetic distance between the coagulation factor IX gene and the locus for the fragile X syndrome: clinical implications.
    Forster-Gibson CJ; Mulligan LM; Partington MW; Simpson NE; Holden JJ; White BN
    J Neurogenet; 1985 Jun; 2(3):231-7. PubMed ID: 3860635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The molecular genetics of the fragile X syndrome. Its molecular diagnosis by DNA probes].
    Giné R; Espinás ML; Antich J; Carballo M
    Med Clin (Barc); 1992 Feb; 98(4):121-4. PubMed ID: 1552760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.